(Q37755977)

22 August 2017

1 reference

title

Transthyretin-related amyloidoses and the heart: a clinical overview (English)

1 reference

22 August 2017

Candida Cristina Quarta

object named as

Candida Cristina Quarta

2

0 references

Elena Biagini

object named as

Elena Biagini

8

0 references

Claudio Rapezzi

object named as

Claudio Rapezzi

1

0 references

author name string

Letizia Riva

3

1 reference

22 August 2017

Simone Longhi

4

1 reference

22 August 2017

Ilaria Gallelli

5

1 reference

22 August 2017

Massimiliano Lorenzini

6

1 reference

22 August 2017

Paolo Ciliberti

7

1 reference

22 August 2017

Fabrizio Salvi

9

1 reference

22 August 2017

Angelo Branzi

10

1 reference

22 August 2017

language of work or name

English

0 references

publication date

18 May 2010

1 reference

Nature Reviews Cardiology

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

7

1 reference

22 August 2017

398-408

1 reference

Scalloped Pupils in Familial Amyloidosis

22 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

21 January 2018

Amyloid heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Amyloidosis and the heart: a comprehensive review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

A primer of amyloid nomenclature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

The molecular biology and clinical features of amyloid neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Fibril in senile systemic amyloidosis is derived from normal transthyretin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Transthyretin-related familial amyloidotic polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Cardiac transplantation for amyloid heart disease: the United Kingdom experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Cardiac amyloidosis: heterogenous pathogenic backgrounds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Phenotypic expression of familial amyloid polyneuropathy in Brazil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Hereditary transthyretin amyloidosis from a Scandinavian perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Familial amyloid polyneuropathy: alanine-for-threonine substitution in the transthyretin (prealbumin) molecule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55-->Pro)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Revised transthyretin Ile 122 allele frequency in African-Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Noninvasive diagnosis of biopsy-proven cardiac amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Evaluation and management of the cardiac amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Cardiovascular magnetic resonance in cardiac amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Nuclear imaging in cardiac amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Amyloidosis: is a cure possible?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

31 March 2020

12 December 2020

Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Clinical practice. Neurogenic orthostatic hypotension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Progression of ventricular wall thickening after liver transplantation for familial amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Combined heart and liver transplantation for familial amyloidotic polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.67

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

31 March 2020

1 reference

12 December 2020

Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man.

1 reference

12 December 2020

[Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family]

1 reference

12 December 2020

Thyroxine-binding proteins

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2010.67

1 reference

22 August 2017

1 reference